vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and i3 Verticals, Inc. (IIIV). Click either name above to swap in a different company.

i3 Verticals, Inc. is the larger business by last-quarter revenue ($52.7M vs $30.9M, roughly 1.7× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs 0.9%, a 45.7% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -14.6%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $13.8M). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs -4.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

The Prusa i3 is a family of fused filament fabrication 3D printers, manufactured by Czech company Prusa Research under the trademarked name Original Prusa i3. Part of the RepRap project, Prusa i3 printers were called the most used 3D printer in the world in 2016. The first Prusa i3 was designed by Josef Průša in 2012, and was released as a commercial kit product in 2015. The latest model is available in both kit and factory assembled versions. The Prusa i3's comparable low cost and ease of co...

CHCT vs IIIV — Head-to-Head

Bigger by revenue
IIIV
IIIV
1.7× larger
IIIV
$52.7M
$30.9M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+20.2% gap
CHCT
5.6%
-14.6%
IIIV
Higher net margin
CHCT
CHCT
45.7% more per $
CHCT
46.6%
0.9%
IIIV
More free cash flow
CHCT
CHCT
$22.1M more FCF
CHCT
$35.9M
$13.8M
IIIV
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
-4.7%
IIIV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CHCT
CHCT
IIIV
IIIV
Revenue
$30.9M
$52.7M
Net Profit
$14.4M
$484.0K
Gross Margin
Operating Margin
3.1%
Net Margin
46.6%
0.9%
Revenue YoY
5.6%
-14.6%
Net Profit YoY
687.6%
-76.5%
EPS (diluted)
$0.52
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
IIIV
IIIV
Q4 25
$30.9M
$52.7M
Q3 25
$31.1M
$46.0M
Q2 25
$29.1M
$51.9M
Q1 25
$30.1M
$63.1M
Q4 24
$29.3M
$52.2M
Q3 24
$29.6M
$32.0M
Q2 24
$27.5M
$46.2M
Q1 24
$29.3M
$58.0M
Net Profit
CHCT
CHCT
IIIV
IIIV
Q4 25
$14.4M
$484.0K
Q3 25
$1.6M
$3.1M
Q2 25
$-12.6M
$12.9M
Q1 25
$1.6M
$-154.0K
Q4 24
$1.8M
$2.1M
Q3 24
$1.7M
$117.9M
Q2 24
$-10.4M
$-7.5M
Q1 24
$3.7M
$1.9M
Operating Margin
CHCT
CHCT
IIIV
IIIV
Q4 25
3.1%
Q3 25
3.2%
Q2 25
-9.3%
Q1 25
8.0%
Q4 24
3.9%
Q3 24
10.6%
Q2 24
-2.8%
Q1 24
3.4%
Net Margin
CHCT
CHCT
IIIV
IIIV
Q4 25
46.6%
0.9%
Q3 25
5.3%
6.7%
Q2 25
-43.2%
24.8%
Q1 25
5.3%
-0.2%
Q4 24
6.3%
3.9%
Q3 24
5.9%
368.2%
Q2 24
-37.9%
-16.3%
Q1 24
12.5%
3.2%
EPS (diluted)
CHCT
CHCT
IIIV
IIIV
Q4 25
$0.52
$0.02
Q3 25
$0.03
$0.14
Q2 25
$-0.50
$0.50
Q1 25
$0.03
$0.00
Q4 24
$0.04
$0.08
Q3 24
$0.04
$4.93
Q2 24
$-0.42
$-0.32
Q1 24
$0.11
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
IIIV
IIIV
Cash + ST InvestmentsLiquidity on hand
$3.3M
$37.5M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$358.5M
Total Assets
$990.8M
$595.9M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
IIIV
IIIV
Q4 25
$3.3M
$37.5M
Q3 25
$3.4M
$66.7M
Q2 25
$4.9M
$55.5M
Q1 25
$2.3M
$7.7M
Q4 24
$4.4M
$85.6M
Q3 24
$2.8M
$86.5M
Q2 24
$734.0K
$9.7M
Q1 24
$3.8M
$3.1M
Total Debt
CHCT
CHCT
IIIV
IIIV
Q4 25
$532.2M
Q3 25
$530.1M
$0
Q2 25
$500.1M
$0
Q1 25
$496.0M
$12.0M
Q4 24
$486.0M
$26.2M
Q3 24
$473.7M
$26.2M
Q2 24
$457.6M
$374.1M
Q1 24
$442.3M
$369.6M
Stockholders' Equity
CHCT
CHCT
IIIV
IIIV
Q4 25
$429.4M
$358.5M
Q3 25
$426.8M
$389.6M
Q2 25
$437.8M
$383.3M
Q1 25
$461.3M
$385.2M
Q4 24
$476.0M
$375.0M
Q3 24
$477.2M
$379.7M
Q2 24
$497.8M
$249.7M
Q1 24
$511.6M
$249.3M
Total Assets
CHCT
CHCT
IIIV
IIIV
Q4 25
$990.8M
$595.9M
Q3 25
$987.3M
$638.4M
Q2 25
$966.3M
$623.3M
Q1 25
$985.1M
$646.4M
Q4 24
$992.6M
$726.2M
Q3 24
$981.8M
$730.7M
Q2 24
$983.2M
$861.7M
Q1 24
$982.7M
$625.8M
Debt / Equity
CHCT
CHCT
IIIV
IIIV
Q4 25
1.24×
Q3 25
1.24×
0.00×
Q2 25
1.14×
0.00×
Q1 25
1.08×
0.03×
Q4 24
1.02×
0.07×
Q3 24
0.99×
0.07×
Q2 24
0.92×
1.50×
Q1 24
0.86×
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
IIIV
IIIV
Operating Cash FlowLast quarter
$56.4M
$14.1M
Free Cash FlowOCF − Capex
$35.9M
$13.8M
FCF MarginFCF / Revenue
116.0%
26.2%
Capex IntensityCapex / Revenue
66.3%
0.6%
Cash ConversionOCF / Net Profit
3.91×
29.18×
TTM Free Cash FlowTrailing 4 quarters
$62.8M
$6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
IIIV
IIIV
Q4 25
$56.4M
$14.1M
Q3 25
$12.7M
$14.0M
Q2 25
$13.8M
$7.4M
Q1 25
$14.4M
$-27.1M
Q4 24
$58.9M
$11.5M
Q3 24
$13.8M
$15.1M
Q2 24
$16.7M
$8.1M
Q1 24
$12.6M
$10.7M
Free Cash Flow
CHCT
CHCT
IIIV
IIIV
Q4 25
$35.9M
$13.8M
Q3 25
$7.6M
$13.5M
Q2 25
$9.6M
$6.8M
Q1 25
$9.7M
$-27.6M
Q4 24
$34.2M
$11.0M
Q3 24
$6.7M
$14.6M
Q2 24
$9.5M
$7.2M
Q1 24
$7.5M
$9.9M
FCF Margin
CHCT
CHCT
IIIV
IIIV
Q4 25
116.0%
26.2%
Q3 25
24.6%
29.5%
Q2 25
32.9%
13.1%
Q1 25
32.3%
-43.8%
Q4 24
116.9%
21.1%
Q3 24
22.5%
45.6%
Q2 24
34.7%
15.6%
Q1 24
25.7%
17.1%
Capex Intensity
CHCT
CHCT
IIIV
IIIV
Q4 25
66.3%
0.6%
Q3 25
16.3%
0.9%
Q2 25
14.5%
1.0%
Q1 25
15.6%
0.8%
Q4 24
84.1%
0.9%
Q3 24
24.2%
1.7%
Q2 24
26.1%
1.9%
Q1 24
17.4%
1.4%
Cash Conversion
CHCT
CHCT
IIIV
IIIV
Q4 25
3.91×
29.18×
Q3 25
7.76×
4.52×
Q2 25
0.57×
Q1 25
9.06×
Q4 24
32.14×
5.59×
Q3 24
7.92×
0.13×
Q2 24
Q1 24
3.45×
5.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHCT
CHCT

Segment breakdown not available.

IIIV
IIIV

License And Service$35.7M68%
Proprietary Payments Revenue$14.5M27%
Other Revenue$2.5M5%

Related Comparisons